Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial

GCM Graziosi, BWJ Mol, PJH Reuwer, A Drogtrop, HW Bruinse

2004-08-01

Abstract:BACKGROUND: Little is known about the effectiveness of misoprostol treatment in women with early pregnancy failure who have been managed expectantly. We therefore performed a randomized trial on this subject. METHODS: Women with early pregnancy failure, who had been managed expectantly for at least 1 week, were assigned randomly (using a computer-generated list) to receive either vaginal misoprostol 800 μg or curettage. If, after 24 h, there had not been complete evacuation, a further 800 μg of misoprostol was administered. In the absence of complete evacuation after >3 days, curettage was performed. The primary end-point was the complete evacuation of the products of conception, with secondary end-points being the occurrence of side effects, pain intensity, need for analgesics, and intensity and duration of bleeding. RESULTS: In the misoprostol group, 47% (37/79) required curettage …